White label ELPA - ClinicalTrials.eu

Perioperative Zanidatamab and Tislelizumab with Chemotherapy for Patients with HER2‑Positive Locally Advanced Operable Gastroesophageal Adenocarcinoma

Not yet recruiting

1 1 1 1
Investigated Diseases:
- Gastrooesophageal cancer
Investigated Drugs:
- Tislelizumab
- Zanidatamab
Postoperative Delirium Incidence and Severity in Patients ≥75 Years Undergoing Femur Osteosynthesis Sedated with Dexmedetomidine vs Propofol

Not yet recruiting

3 1 1 1
Investigated Diseases:
- Postoperative delirium
Investigated Drugs:
- Dexmedetomidine
- Propofol
Effects of metyrapone and hydrocortisone on cardio‑metabolic health and circadian rhythm in patients with mild autonomous cortisol secretion

Not yet recruiting

3 1 1
Investigated Diseases:
- Cortisol abnormal
Investigated Drugs:
- Metyrapone
- Hydrocortisone
Evaluation of 68Ga-FAPI-46 and Fluor-18-FDG PET/MRI in Paediatric Sarcoma Patients

Not yet recruiting

2 1 1 1
Investigated Diseases:
- Sarcoma
Investigated Drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
- Fludeoxyglucose (18F)
Efficacy and Safety of Amara‑Tropfen Dilution vs Placebo in Patients with Irritable Bowel Syndrome

Not yet recruiting

3 1 1
Investigated Diseases:
- Irritable bowel syndrome
Efficacy and Safety of Lucerastat in Treatment‑Naïve Adult Male Patients with Fabry Disease

Not yet recruiting

3 1 1
Investigated Diseases:
- Fabry’s disease
Investigated Drugs:
- Lucerastat
Prehospital Sedation with Esketamine versus Propofol in Patients with Severe Acute Brain Injury

Not yet recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
- Esketamine Hydrochloride
- Propofol
Safety and efficacy of oral ACT-777991 in adults with non‑segmental vitiligo: a randomized, double‑blind, placebo‑controlled Phase 2a trial

Not yet recruiting

2 1
Study of Rinatabart Sesutecan with glatiramer acetate in patients with advanced gastrointestinal cancers

Not yet recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Glatiramer Acetate
- HUMAN IGG1 KAPPA MONOCLONAL ANTIBODY AGAINST FOLR1 CONJUGATED TO 1-[(2R,3R,4R,5S,52S)-1,2,3,4,5-PENTAHYDROXY-52-{[(2S)-1-{[(2S)-5-CARBAMOYLAMINO-1-OXO-1-{3-[({[(1S,9S)-9-ETHYL-5-FLUORO-9-HYDROXY-4-METHYL10,13-DIOXO-2,3,9,10,13,15-HEXAHYDRO-1H,12HBENZO[DE]PYRANO[3′,4′:6,7]INDOLIZINO[1,2-B]QUINOLIN-1-YL]CARBAMOYL}OXY)METHYL]ANILINO}PENTAN-2-YL]AMINO}-3-METHYL-1-OXOBUTAN-2-YL]CARBAMOYL}-7-[(2S,3R,4R,5R)-2,3,4,5,6-PENTAHYDROXYHEXYL]-46,54-DIOXO10,13,16,19,22,25,28,31,34,37,40,43-DODECAOXA-7,47,53-TRIAZANONAPENTACONTAN-59-YL]-2,5-DIOXOPYRROLIDIN-3-YL
+1
Short-Acting Pasireotide Test to Predict Treatment Response in Patients with Acromegaly

Not yet recruiting

2 1 1 1
Investigated Drugs:
- Pasireotide

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies